These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18952634)

  • 41. The impaired flow reserve capacity of penetrating intramyocardial coronary arteries in apical hypertrophic cardiomyopathy.
    Youn HJ; Lee JM; Park CS; Ihm SH; Cho EJ; Jung HO; Jeon HK; Oh YS; Chung WS; Kim JH; Choi KB; Hong SJ
    J Am Soc Echocardiogr; 2005 Feb; 18(2):128-32. PubMed ID: 15682049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: outcomes in young, middle-aged, and elderly patients.
    Leonardi RA; Townsend JC; Patel CA; Wolf BJ; Todoran TM; Powers ER; Steinberg DH; Fernandes VL; Nielsen CD
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):838-45. PubMed ID: 22936613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic implications of coronary flow reserve on left anterior descending coronary artery in hypertrophic cardiomyopathy.
    Cortigiani L; Rigo F; Gherardi S; Galderisi M; Sicari R; Picano E
    Am J Cardiol; 2008 Dec; 102(12):1718-23. PubMed ID: 19064030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy.
    Gietzen FH; Leuner CJ; Raute-Kreinsen U; Dellmann A; Hegselmann J; Strunk-Mueller C; Kuhn HJ
    Eur Heart J; 1999 Sep; 20(18):1342-54. PubMed ID: 10462469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alcohol septal ablation versus surgical myectomy: a patient with obstructive HCM.
    La Canna G; Airoldi F; Capritti E; Grimaldi A; Colombo A; Alfieri O
    Nat Clin Pract Cardiovasc Med; 2007 Oct; 4(10):570-6. PubMed ID: 17893685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormal longitudinal myocardial functional reserve assessed by exercise tissue Doppler echocardiography in patients with hypertrophic cardiomyopathy.
    Ha JW; Ahn JA; Kim JM; Choi EY; Kang SM; Rim SJ; Jang Y; Shim WH; Cho SY; Oh JK; Chung N
    J Am Soc Echocardiogr; 2006 Nov; 19(11):1314-9. PubMed ID: 17098132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term prognostic value of coronary flow velocity reserve in patients with hypertrophic cardiomyopathy: 9-year follow-up results from SZEGED study.
    Nemes A; Balázs E; Soliman OI; Sepp R; Csanády M; Forster T
    Heart Vessels; 2009 Sep; 24(5):352-6. PubMed ID: 19784818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute effects of alcohol septal ablation on systolic and diastolic left ventricular function in patients with hypertrophic obstructive cardiomyopathy.
    Steendijk P; Meliga E; Valgimigli M; Ten Cate FJ; Serruys PW
    Heart; 2008 Oct; 94(10):1318-22. PubMed ID: 18450844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on left-ventricular mechanical dyssynchrony as assessed by phase analysis of gated SPECT myocardial perfusion imaging.
    Chen J; Nagaraj H; Bhambhani P; Kliner DE; Soman P; Garcia EV; Heo J; Iskandrian AE
    Int J Cardiovasc Imaging; 2012 Aug; 28(6):1375-84. PubMed ID: 21863321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mid-systolic septal deceleration. A new sign of left ventricular outflow tract obstruction obtained by color-coded tissue Doppler echocardiography.
    Breithardt OA; Stolle B; Franke A; Janssens U; Hanrath P; Kuhn H
    Z Kardiol; 2003 Dec; 92(12):1003-7. PubMed ID: 14663610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Role of Doppler echocardiography in the diagnostics and therapy of hypertrophic cardiomyopathy].
    Veselka J
    Cas Lek Cesk; 2006; 145(4):279-83. PubMed ID: 16639927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of coronary flow with transthoracic color Doppler echocardiography in patients with hypertrophic cardiomyopathy.
    Ferreiro DE; Cianciulli TF; Saccheri MC; Lax JA; Celano L; Beck MA; Gagliardi JA; Kazelián LR; Neme RO
    Echocardiography; 2013 Nov; 30(10):1156-63. PubMed ID: 23662893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of alcohol septal ablation in patients with symptomatic concentric left ventricular hypertrophy and outflow tract obstruction.
    Kovacic JC; Khanna D; Kaplish D; Karajgikar R; Sharma SK; Kini A
    J Invasive Cardiol; 2010 Dec; 22(12):586-91. PubMed ID: 21127363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Left ventricular diastolic reserve during acute pressure loading in hypertrophic cardiomyopathy and dilated cardiomyopathy].
    Yokote Y; Okamoto M; Sakura E; Shimamoto H; Amioka H; Yamagata T; Hashimoto M; Tsuchioka Y; Matsuura H; Kajiyama G
    J Cardiol; 1988 Dec; 18(4):1051-60. PubMed ID: 3267714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion.
    Kuhn H; Gietzen FH; Schäfers M; Freick M; Gockel B; Strunk-Müller C; Jachmann E; Schober O
    Eur Heart J; 1999 Dec; 20(24):1808-17. PubMed ID: 10581139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis.
    van Dockum WG; Kuijer JP; Götte MJ; Ten Cate FJ; Ten Berg JM; Beek AM; Twisk JW; Marcus JT; Visser CA; van Rossum AC
    Eur Heart J; 2006 Dec; 27(23):2833-9. PubMed ID: 17098761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Alcohol concentration in the coronary sinus after transarterial ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy].
    Klein N; Mende M; Hagendorff A; Neugebauer A; Pfeiffer D
    Dtsch Med Wochenschr; 2000 May; 125(19):579-83. PubMed ID: 11320715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
    Alam M; Dokainish H; Lakkis NM
    Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of coronary blood flow in hypertrophic cardiomyopathy using thrombolysis in myocardial infarction frame count method.
    Yasar AS; Turhan H; Erbay AR; Karabal O; Bicer A; Sasmaz H; Yetkin E
    J Invasive Cardiol; 2005 Feb; 17(2):73-6. PubMed ID: 15687528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New approach to septal ablation: glue (cyanoacrylate) septal ablation.
    Oto A; Aytemir K; Deniz A
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):1021-5. PubMed ID: 17525960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.